Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Temsujohn 0.2mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Tamsulosin (0.2mg)

Overview Temsujohn 0.2mg Tablet ER

Alfuzosin extended-release 0.2mg tablets are alpha-blockers indicated for benign prostatic hyperplasia (BPH). This medication alleviates urinary symptoms such as hesitancy, but doesn't reduce prostate volume. Always follow your physician's prescribed dosage and schedule. It can be taken with or without food, but maintain consistent timing. Swallow the tablet whole; do not crush or chew. Discontinue use only under medical supervision, as abrupt cessation may worsen symptoms. Complete the prescribed course for optimal results. Common side effects include lightheadedness, back discomfort, chest pain, impaired ejaculation, and retrograde ejaculation. Report any persistent or bothersome side effects promptly to your doctor. Lifestyle adjustments can improve symptom management. Urinate when you feel the need, but avoid straining. Limit or avoid caffeinated and alcoholic beverages close to bedtime. Prior to treatment, disclose all other medications and health conditions to your doctor. If undergoing cataract or glaucoma surgery, inform your ophthalmologist about alfuzosin use. Patients with hepatic impairment should exercise caution, receiving regular monitoring as directed by their physician.

Uses of Temsujohn 0.2mg Tablet ER

Managing benign prostatic enlargement

Major Benefits of Temsujohn 0.2mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Temsujohn 0.2mg Extended-Release Tablet can be consumed with or without food, although consistent daily timing is recommended.

Common Side effects of Temsujohn 0.2mg Tablet ER:

  • Chest pain
  • Inflammation of the nose
  • Dizziness
  • Ejaculation disorder
  • Headache
  • Abdominal pain
  • Back pain
  • Nausea
  • Infection

How to use Temsujohn 0.2mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Temsujohn 0.2mg Extended-Release Tablet can be consumed with or without food, though consistent daily timing is recommended.

How Temsujohn 0.2mg Tablet ER works:

Temsujohn 0.2mg Extended-Release tablets function as an alpha-adrenergic antagonist. By relaxing the muscles in the bladder neck and prostate, they facilitate smoother urine flow, promoting complete bladder emptying and lessening the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Temsujohn 0.2mg Extended-Release tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The safety of Temsujohn 0.2mg Extended-Release Tablet during pregnancy is unknown. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Temsujohn 0.2mg Extended-Release Tablets while breastfeeding is likely unsafe. Available human data suggests potential drug transfer via breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.

DrivingDrivingSAFE

Driving ability is typically unaffected by Temsujohn 0.2mg Extended-Release Tablets.

KidneyKidneySAFE IF PRESCRIBED

Temsujohn 0.2mg Extended-Release tablets are considered safe for individuals with kidney impairment; no dosage modification is typically necessary. Nevertheless, data regarding its use in patients experiencing end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with severe hepatic impairment should exercise caution when using Temsujohn 0.2mg Extended-Release tablets. Dosage modification of Temsujohn 0.2mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Temsujohn 0.2mg Tablet ER :

Should you forget to take a Temsujohn 0.2mg Extended-Release Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Temsujohn 0.2mg Tablet ER

LabelValue
Chemical Type Sulfonamide-based compound
Developing Habits No.
Treatment Category Urological Care

FAQs on Temsujohn 0.2mg Tablet ER

Take the capsule once daily, approximately 30 minutes after your first meal (breakfast or dinner, as preferred; some doctors recommend nighttime). Swallow it whole with water; do not crush or chew.
Temsulosin 0.2mg Extended-Release tablets do not raise blood sugar. Report any blood sugar level changes to your doctor, as this may indicate a separate medical condition requiring treatment.
Temsujohn 0.2mg Tablet ER typically doesn't cause weight gain, even with prolonged use. However, if you do gain weight while taking it, consult your doctor.
You may notice improved urine flow within 4 to 8 hours of taking a 0.2mg Temsulosin extended-release tablet, but complete symptom relief can take 2 to 4 weeks.
Yes, Temsujohn 0.2mg Extended-Release tablets can be safely taken with vitamin D; no adverse interactions are known.
Temsujohn 0.2mg Extended-Release tablets aid in the urinary excretion of kidney stones. This occurs by relaxing the urinary tract muscles, facilitating easier stone passage and reducing the need for pain medication.
Temsujohn 0.2mg Extended-Release tablets dilate blood vessels in the extremities, causing blood to pool there. This reduced blood flow to the brain leads to postural hypotension, potentially resulting in dizziness, lightheadedness, fainting, vertigo, or a spinning sensation.
Temsujohn 0.2mg Extended-Release tablets may induce floppy iris syndrome, causing unexpected pupil constriction during cataract surgery. This constriction can severely limit the surgeon's view, potentially compromising surgical results.
Temsujohn 0.2mg Extended-Release tablets relax blood vessel muscles, potentially causing nasal congestion.
Temsujohn 0.2mg Tablet ER isn't an anticholinergic. It eases prostate and bladder neck muscle contractions, thereby improving urine flow in men with benign prostatic hyperplasia. Concurrent use with anticholinergics can exacerbate symptoms.
Temsujohn 0.2mg Tablet ER doesn't cause frequent urination; instead, it improves urine flow and reduces urinary urgency, common symptoms of benign prostatic hyperplasia (BPH). BPH also often involves a weak urinary stream and incomplete bladder emptying. Temsujohn 0.2mg Tablet ER treats these urinary symptoms associated with BPH.
While Temsujohn 0.2mg Tablet ER typically doesn't cause side effects in patients with benign prostatic hyperplasia, prolonged use might increase the risk of infections (including rhinitis and pharyngitis), pain, ejaculatory dysfunction, and cardiovascular events such as syncope and hypotension.
Managing your symptoms involves simple lifestyle adjustments. Respond promptly to the urge to urinate, but avoid straining. Limit fluids, particularly alcohol and caffeine, several hours before sleep or outings. Always consult your doctor before taking any additional medication, as some can worsen urinary urgency.
Temsujohn 0.2mg Extended-Release tablets may be taken concurrently with ibuprofen or paracetamol without known adverse interactions.
Temsujohn 0.2mg Tablet ER
53
MRP 65
18% off